(19)
(11) EP 4 139 450 A1

(12)

(43) Date of publication:
01.03.2023 Bulletin 2023/09

(21) Application number: 21721806.4

(22) Date of filing: 15.04.2021
(51) International Patent Classification (IPC): 
C12N 15/10(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/1003; A01N 1/0226
(86) International application number:
PCT/US2021/027573
(87) International publication number:
WO 2021/216353 (28.10.2021 Gazette 2021/43)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 20.04.2020 US 202063012637 P
08.01.2021 WO PCT/US2021/012844

(71) Applicant: SiO2 Medical Products, Inc.
Auburn, AL 36832 (US)

(72) Inventors:
  • PICCIRILLI, Joseph
    Chicago, IL 60605 (US)
  • WEIKART, Christopher
    Auburn, AL 36832 (US)
  • KLIBANOV, Alexander M.
    Auburn, AL 36832 (US)
  • HEXOM, Tia
    Auburn, AL 36832 (US)
  • NUNEZ, Brandy
    Fullerton, CA 92833 (US)

(74) Representative: Lau, Sarah Jane et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) NUCLEIC ACID AND CELL PRESERVATIVE COMPOSITIONS AND METHODS OF USE